Department of Electrical and Computer Engineering, Texas A&M University, College Station, TX, USA.
Department of Chemical Engineering, Texas A&M University, College Station, TX, USA.
Biomed Microdevices. 2024 May 29;26(2):26. doi: 10.1007/s10544-024-00712-3.
Three-dimensional (3D) cell culture models have been extensively utilized in various mechanistic studies as well as for drug development studies as superior in vitro platforms than conventional two-dimensional (2D) cell culture models. This is especially the case in cancer biology, where 3D cancer models, such as spheroids or organoids, have been utilized extensively to understand the mechanisms of cancer development. Recently, many sophisticated 3D models such as organ-on-a-chip models are emerging as advanced in vitro models that can more accurately mimic the in vivo tissue functions. Despite such advancements, spheroids are still considered as a powerful 3D cancer model due to the relatively simple structure and compatibility with existing laboratory instruments, and also can provide orders of magnitude higher throughput than complex in vitro models, an extremely important aspects for drug development. However, creating well-defined spheroids remain challenging, both in terms of throughputs in generation as well as reproducibility in size and shape that can make it challenging for drug testing applications. In the past decades, droplet microfluidics utilizing hydrogels have been highlighted due to their potentials. Importantly, core-shell structured gel droplets can avoid spheroid-to-spheroid adhesion that can cause large variations in assays while also enabling long-term cultivation of spheroids with higher uniformity by protecting the core organoid area from external environment while the outer porous gel layer still allows nutrient exchange. Hence, core-shell gel droplet-based spheroid formation can improve the predictivity and reproducibility of drug screening assays. This review paper will focus on droplet microfluidics-based technologies for cancer spheroid production using various gel materials and structures. In addition, we will discuss emerging technologies that have the potential to advance the production of spheroids, prospects of such technologies, and remaining challenges.
三维(3D)细胞培养模型已被广泛应用于各种机制研究以及药物开发研究中,作为优于传统二维(2D)细胞培养模型的体外平台。在癌症生物学中尤其如此,其中 3D 癌症模型,如球体或类器官,已被广泛用于理解癌症发展的机制。最近,许多复杂的 3D 模型,如器官芯片模型,作为先进的体外模型出现,可以更准确地模拟体内组织功能。尽管取得了这些进展,但球体仍然被认为是一种强大的 3D 癌症模型,因为其结构相对简单,与现有实验室仪器兼容,并且可以提供比复杂的体外模型高出几个数量级的高通量,这对于药物开发来说是一个极其重要的方面。然而,由于生成的通量以及尺寸和形状的可重复性方面的挑战,创建具有明确定义的球体仍然具有挑战性,这可能会使药物测试应用变得具有挑战性。在过去的几十年中,利用水凝胶的液滴微流控技术因其潜力而受到关注。重要的是,核壳结构的凝胶液滴可以避免球体之间的粘连,从而在分析中产生较大的变化,同时通过保护核心类器官区域免受外部环境的影响,允许长期培养具有更高均匀性的球体,而外部多孔凝胶层仍然允许营养物质交换。因此,基于核壳凝胶液滴的球体形成可以提高药物筛选分析的预测性和重现性。本文综述了基于液滴微流控技术的各种凝胶材料和结构的癌症球体生产技术。此外,我们将讨论具有潜在推进球体生产的新兴技术、这些技术的前景以及仍然存在的挑战。